Previous Page  33 / 38 Next Page
Information
Show Menu
Previous Page 33 / 38 Next Page
Page Background

PROSPER/SPARTAN

: primary end-point MFS

Smith MR, et al. NEJM 2018; Hussain M, et al. NEJM 2018